Characteristics and Outcomes of Long-Stay Patients in the Pediatric Intensive Care Unit

Angela Hui Ping Kirk1, Qian Wen Sng1, Lu Qin Zhang1

  • 1Division of Nursing, KK Women's and Children's Hospital, Singapore.

Insights

Long-stay patients in the Pediatric Intensive Care Unit (PICU) face higher mortality risks. Key risk factors include severe illness, organ support, infections, and particularly, a pre-existing oncologic diagnosis.

Area of Science:

  • Pediatric Critical Care Medicine
  • Oncology
  • Infectious Diseases

Background:

  • Long-stay patients in the Pediatric Intensive Care Unit (PICU) are recognized as a vulnerable population.
  • These patients often have complex medical needs and prolonged hospitalizations, increasing their risk of adverse outcomes compared to short-stay patients.

Purpose of the Study:

  • To characterize the mortality rates and patient demographics of long-stay admissions in the PICU.
  • To identify specific risk factors associated with increased mortality in this high-risk group.

Main Methods:

  • Retrospective analysis of 241 long-stay admissions (4.8% of total admissions).
  • Data collection included severity-of-illness scores, organ support requirements, incidence of nosocomial infections, and pre-existing comorbidities.
  • Multivariate analysis was employed to determine independent predictors of mortality.

Main Results:

  • The overall mortality rate for long-stay patients was 20% (48 out of 241).
  • Factors significantly associated with higher mortality included higher admission severity-of-illness scores, requirement for organ support therapies, and a greater number of nosocomial infections, especially bloodstream infections.
  • Oncologic diagnosis emerged as a strong independent predictor of mortality.

Conclusions:

  • Long-stay PICU patients exhibit a substantial mortality rate.
  • Early identification of high-risk factors such as severe illness, organ dysfunction, infections, and oncologic diagnoses is crucial for targeted interventions.
  • An oncologic diagnosis is a significant independent risk factor for mortality in long-stay PICU patients, highlighting the need for specialized care pathways.

Related Concept Videos

Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.9K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
200
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
261
Measurement: Derived Units03:02

Measurement: Derived Units

The International System of Units or SI system, by international agreement, has fixed measurement units for seven fundamental properties: length, mass, time, temperature, electric current, amount of substance, and luminosity. These are called the SI base units.
54.6K